nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Scleroderma—Docetaxel—head and neck cancer	0.0434	0.0486	CcSEcCtD
Cilazapril—ACE—forelimb zeugopod—head and neck cancer	0.0388	0.365	CbGeAlD
Cilazapril—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0204	0.0229	CcSEcCtD
Cilazapril—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0182	0.0204	CcSEcCtD
Cilazapril—Digestion impaired—Hydroxyurea—head and neck cancer	0.0169	0.0189	CcSEcCtD
Cilazapril—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0137	0.0154	CcSEcCtD
Cilazapril—Raised liver function tests—Docetaxel—head and neck cancer	0.0127	0.0142	CcSEcCtD
Cilazapril—Photophobia—Vinblastine—head and neck cancer	0.0116	0.013	CcSEcCtD
Cilazapril—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.0106	0.0119	CcSEcCtD
Cilazapril—Necrosis—Fluorouracil—head and neck cancer	0.0104	0.0116	CcSEcCtD
Cilazapril—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0103	0.0115	CcSEcCtD
Cilazapril—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0101	0.0113	CcSEcCtD
Cilazapril—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00919	0.0103	CcSEcCtD
Cilazapril—Renal failure acute—Hydroxyurea—head and neck cancer	0.00889	0.00995	CcSEcCtD
Cilazapril—Face oedema—Hydroxyurea—head and neck cancer	0.00793	0.00887	CcSEcCtD
Cilazapril—Rash erythematous—Docetaxel—head and neck cancer	0.00767	0.00858	CcSEcCtD
Cilazapril—Photophobia—Fluorouracil—head and neck cancer	0.00764	0.00855	CcSEcCtD
Cilazapril—Angina pectoris—Vinblastine—head and neck cancer	0.00758	0.00848	CcSEcCtD
Cilazapril—Necrosis—Docetaxel—head and neck cancer	0.00749	0.00838	CcSEcCtD
Cilazapril—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0074	0.00828	CcSEcCtD
Cilazapril—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00731	0.00818	CcSEcCtD
Cilazapril—Rigors—Docetaxel—head and neck cancer	0.0072	0.00805	CcSEcCtD
Cilazapril—ACE—mouth—head and neck cancer	0.00701	0.066	CbGeAlD
Cilazapril—Pancreatitis—Hydroxyurea—head and neck cancer	0.00696	0.00778	CcSEcCtD
Cilazapril—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00684	0.00765	CcSEcCtD
Cilazapril—Myocardial infarction—Vinblastine—head and neck cancer	0.0068	0.00761	CcSEcCtD
Cilazapril—Photosensitivity—Fluorouracil—head and neck cancer	0.00673	0.00753	CcSEcCtD
Cilazapril—Neutropenia—Hydroxyurea—head and neck cancer	0.00664	0.00742	CcSEcCtD
Cilazapril—Dysuria—Hydroxyurea—head and neck cancer	0.00664	0.00742	CcSEcCtD
Cilazapril—Agranulocytosis—Vinblastine—head and neck cancer	0.00647	0.00724	CcSEcCtD
Cilazapril—Hypoaesthesia—Vinblastine—head and neck cancer	0.0062	0.00693	CcSEcCtD
Cilazapril—Pharyngitis—Vinblastine—head and neck cancer	0.00618	0.00692	CcSEcCtD
Cilazapril—SLC15A2—mouth—head and neck cancer	0.00611	0.0575	CbGeAlD
Cilazapril—Cardiac failure—Fluorouracil—head and neck cancer	0.00606	0.00678	CcSEcCtD
Cilazapril—ACE—neck—head and neck cancer	0.00599	0.0564	CbGeAlD
Cilazapril—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00598	0.00669	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00591	0.00661	CcSEcCtD
Cilazapril—SLC15A1—epithelium—head and neck cancer	0.00569	0.0535	CbGeAlD
Cilazapril—Ataxia—Fluorouracil—head and neck cancer	0.00556	0.00622	CcSEcCtD
Cilazapril—Alopecia—Vinblastine—head and neck cancer	0.0055	0.00616	CcSEcCtD
Cilazapril—Angiopathy—Hydroxyurea—head and neck cancer	0.00515	0.00577	CcSEcCtD
Cilazapril—Chills—Hydroxyurea—head and neck cancer	0.0051	0.0057	CcSEcCtD
Cilazapril—Ill-defined disorder—Vinblastine—head and neck cancer	0.00503	0.00563	CcSEcCtD
Cilazapril—Alopecia—Hydroxyurea—head and neck cancer	0.00502	0.00562	CcSEcCtD
Cilazapril—Anaemia—Vinblastine—head and neck cancer	0.00501	0.00561	CcSEcCtD
Cilazapril—Angina pectoris—Fluorouracil—head and neck cancer	0.00498	0.00557	CcSEcCtD
Cilazapril—Malaise—Vinblastine—head and neck cancer	0.00489	0.00547	CcSEcCtD
Cilazapril—Vertigo—Vinblastine—head and neck cancer	0.00487	0.00545	CcSEcCtD
Cilazapril—Leukopenia—Vinblastine—head and neck cancer	0.00485	0.00543	CcSEcCtD
Cilazapril—Cardiac failure congestive—Docetaxel—head and neck cancer	0.0047	0.00526	CcSEcCtD
Cilazapril—Hypertension—Vinblastine—head and neck cancer	0.00468	0.00524	CcSEcCtD
Cilazapril—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00466	0.00522	CcSEcCtD
Cilazapril—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00459	0.00513	CcSEcCtD
Cilazapril—Anaemia—Hydroxyurea—head and neck cancer	0.00457	0.00511	CcSEcCtD
Cilazapril—Discomfort—Vinblastine—head and neck cancer	0.00456	0.0051	CcSEcCtD
Cilazapril—Hot flush—Docetaxel—head and neck cancer	0.00456	0.0051	CcSEcCtD
Cilazapril—Menopausal symptoms—Docetaxel—head and neck cancer	0.00452	0.00506	CcSEcCtD
Cilazapril—Atrial fibrillation—Docetaxel—head and neck cancer	0.0045	0.00504	CcSEcCtD
Cilazapril—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00449	0.00502	CcSEcCtD
Cilazapril—Renal impairment—Docetaxel—head and neck cancer	0.00448	0.00501	CcSEcCtD
Cilazapril—Myocardial infarction—Fluorouracil—head and neck cancer	0.00446	0.00499	CcSEcCtD
Cilazapril—Malaise—Hydroxyurea—head and neck cancer	0.00446	0.00499	CcSEcCtD
Cilazapril—Conjunctivitis—Fluorouracil—head and neck cancer	0.00443	0.00495	CcSEcCtD
Cilazapril—Leukopenia—Hydroxyurea—head and neck cancer	0.00443	0.00495	CcSEcCtD
Cilazapril—Cardiac failure—Docetaxel—head and neck cancer	0.00437	0.00489	CcSEcCtD
Cilazapril—Thrombocytopenia—Vinblastine—head and neck cancer	0.00433	0.00485	CcSEcCtD
Cilazapril—Epistaxis—Fluorouracil—head and neck cancer	0.0043	0.00481	CcSEcCtD
Cilazapril—ACE—connective tissue—head and neck cancer	0.00429	0.0404	CbGeAlD
Cilazapril—Sinusitis—Fluorouracil—head and neck cancer	0.00427	0.00478	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00427	0.00477	CcSEcCtD
Cilazapril—SLC15A2—parotid gland—head and neck cancer	0.00425	0.04	CbGeAlD
Cilazapril—Agranulocytosis—Fluorouracil—head and neck cancer	0.00425	0.00475	CcSEcCtD
Cilazapril—Anorexia—Vinblastine—head and neck cancer	0.00422	0.00472	CcSEcCtD
Cilazapril—Migraine—Docetaxel—head and neck cancer	0.0042	0.0047	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00418	0.00468	CcSEcCtD
Cilazapril—Discomfort—Hydroxyurea—head and neck cancer	0.00416	0.00465	CcSEcCtD
Cilazapril—Rhinitis—Fluorouracil—head and neck cancer	0.0041	0.00459	CcSEcCtD
Cilazapril—ACE—epithelium—head and neck cancer	0.00408	0.0384	CbGeAlD
Cilazapril—SLC15A2—saliva-secreting gland—head and neck cancer	0.00407	0.0384	CbGeAlD
Cilazapril—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00407	0.00455	CcSEcCtD
Cilazapril—Pharyngitis—Fluorouracil—head and neck cancer	0.00406	0.00454	CcSEcCtD
Cilazapril—Oedema—Hydroxyurea—head and neck cancer	0.00404	0.00451	CcSEcCtD
Cilazapril—Ataxia—Docetaxel—head and neck cancer	0.00401	0.00449	CcSEcCtD
Cilazapril—Paraesthesia—Vinblastine—head and neck cancer	0.00397	0.00445	CcSEcCtD
Cilazapril—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00395	0.00442	CcSEcCtD
Cilazapril—Liver function test abnormal—Docetaxel—head and neck cancer	0.00394	0.00441	CcSEcCtD
Cilazapril—Skin disorder—Hydroxyurea—head and neck cancer	0.00392	0.00439	CcSEcCtD
Cilazapril—Orthostatic hypotension—Docetaxel—head and neck cancer	0.0039	0.00436	CcSEcCtD
Cilazapril—Anorexia—Hydroxyurea—head and neck cancer	0.00385	0.0043	CcSEcCtD
Cilazapril—Decreased appetite—Vinblastine—head and neck cancer	0.00385	0.0043	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00384	0.0043	CcSEcCtD
Cilazapril—Constipation—Vinblastine—head and neck cancer	0.00378	0.00423	CcSEcCtD
Cilazapril—Pain—Vinblastine—head and neck cancer	0.00378	0.00423	CcSEcCtD
Cilazapril—Arrhythmia—Fluorouracil—head and neck cancer	0.00365	0.00409	CcSEcCtD
Cilazapril—Feeling abnormal—Vinblastine—head and neck cancer	0.00365	0.00408	CcSEcCtD
Cilazapril—Bronchospasm—Docetaxel—head and neck cancer	0.00363	0.00406	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00362	0.00405	CcSEcCtD
Cilazapril—Alopecia—Fluorouracil—head and neck cancer	0.00361	0.00404	CcSEcCtD
Cilazapril—Dyspnoea—Hydroxyurea—head and neck cancer	0.0036	0.00403	CcSEcCtD
Cilazapril—Angina pectoris—Docetaxel—head and neck cancer	0.00359	0.00402	CcSEcCtD
Cilazapril—Somnolence—Hydroxyurea—head and neck cancer	0.00359	0.00401	CcSEcCtD
Cilazapril—Dyspepsia—Hydroxyurea—head and neck cancer	0.00355	0.00397	CcSEcCtD
Cilazapril—Decreased appetite—Hydroxyurea—head and neck cancer	0.00351	0.00392	CcSEcCtD
Cilazapril—Abdominal pain—Vinblastine—head and neck cancer	0.0035	0.00391	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00348	0.0039	CcSEcCtD
Cilazapril—Fatigue—Hydroxyurea—head and neck cancer	0.00348	0.00389	CcSEcCtD
Cilazapril—Constipation—Hydroxyurea—head and neck cancer	0.00345	0.00386	CcSEcCtD
Cilazapril—Pain—Hydroxyurea—head and neck cancer	0.00345	0.00386	CcSEcCtD
Cilazapril—Neutropenia—Docetaxel—head and neck cancer	0.00345	0.00386	CcSEcCtD
Cilazapril—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00333	0.00372	CcSEcCtD
Cilazapril—Anaemia—Fluorouracil—head and neck cancer	0.00329	0.00368	CcSEcCtD
Cilazapril—Hypersensitivity—Vinblastine—head and neck cancer	0.00326	0.00365	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00326	0.00365	CcSEcCtD
Cilazapril—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00324	0.00363	CcSEcCtD
Cilazapril—Renal failure—Docetaxel—head and neck cancer	0.00323	0.00362	CcSEcCtD
Cilazapril—Myocardial infarction—Docetaxel—head and neck cancer	0.00322	0.0036	CcSEcCtD
Cilazapril—Conjunctivitis—Docetaxel—head and neck cancer	0.00319	0.00357	CcSEcCtD
Cilazapril—Leukopenia—Fluorouracil—head and neck cancer	0.00319	0.00356	CcSEcCtD
Cilazapril—Asthenia—Vinblastine—head and neck cancer	0.00317	0.00355	CcSEcCtD
Cilazapril—SLC15A2—trachea—head and neck cancer	0.00314	0.0296	CbGeAlD
Cilazapril—ACE—lymphoid tissue—head and neck cancer	0.00314	0.0296	CbGeAlD
Cilazapril—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00311	0.00348	CcSEcCtD
Cilazapril—Epistaxis—Docetaxel—head and neck cancer	0.0031	0.00347	CcSEcCtD
Cilazapril—Agranulocytosis—Docetaxel—head and neck cancer	0.00307	0.00343	CcSEcCtD
Cilazapril—Chest pain—Fluorouracil—head and neck cancer	0.00303	0.00339	CcSEcCtD
Cilazapril—Myalgia—Fluorouracil—head and neck cancer	0.00303	0.00339	CcSEcCtD
Cilazapril—Diarrhoea—Vinblastine—head and neck cancer	0.00303	0.00339	CcSEcCtD
Cilazapril—Discomfort—Fluorouracil—head and neck cancer	0.00299	0.00335	CcSEcCtD
Cilazapril—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00297	0.00333	CcSEcCtD
Cilazapril—Rhinitis—Docetaxel—head and neck cancer	0.00296	0.00331	CcSEcCtD
Cilazapril—Hypoaesthesia—Docetaxel—head and neck cancer	0.00294	0.00328	CcSEcCtD
Cilazapril—Confusional state—Fluorouracil—head and neck cancer	0.00293	0.00328	CcSEcCtD
Cilazapril—Pharyngitis—Docetaxel—head and neck cancer	0.00293	0.00328	CcSEcCtD
Cilazapril—Dizziness—Vinblastine—head and neck cancer	0.00293	0.00327	CcSEcCtD
Cilazapril—Urinary tract disorder—Docetaxel—head and neck cancer	0.00291	0.00326	CcSEcCtD
Cilazapril—Oedema—Fluorouracil—head and neck cancer	0.0029	0.00325	CcSEcCtD
Cilazapril—Asthenia—Hydroxyurea—head and neck cancer	0.0029	0.00324	CcSEcCtD
Cilazapril—Urethral disorder—Docetaxel—head and neck cancer	0.00289	0.00324	CcSEcCtD
Cilazapril—ACE—thyroid gland—head and neck cancer	0.00285	0.0268	CbGeAlD
Cilazapril—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00284	0.00318	CcSEcCtD
Cilazapril—Visual impairment—Docetaxel—head and neck cancer	0.00284	0.00318	CcSEcCtD
Cilazapril—Tachycardia—Fluorouracil—head and neck cancer	0.00283	0.00317	CcSEcCtD
Cilazapril—Vomiting—Vinblastine—head and neck cancer	0.00281	0.00315	CcSEcCtD
Cilazapril—Erythema multiforme—Docetaxel—head and neck cancer	0.00279	0.00312	CcSEcCtD
Cilazapril—Headache—Vinblastine—head and neck cancer	0.00277	0.0031	CcSEcCtD
Cilazapril—Anorexia—Fluorouracil—head and neck cancer	0.00277	0.0031	CcSEcCtD
Cilazapril—Diarrhoea—Hydroxyurea—head and neck cancer	0.00276	0.00309	CcSEcCtD
Cilazapril—Flushing—Docetaxel—head and neck cancer	0.00274	0.00306	CcSEcCtD
Cilazapril—Cardiac disorder—Docetaxel—head and neck cancer	0.00274	0.00306	CcSEcCtD
Cilazapril—Hypotension—Fluorouracil—head and neck cancer	0.00271	0.00304	CcSEcCtD
Cilazapril—Angiopathy—Docetaxel—head and neck cancer	0.00268	0.003	CcSEcCtD
Cilazapril—Dizziness—Hydroxyurea—head and neck cancer	0.00267	0.00299	CcSEcCtD
Cilazapril—Immune system disorder—Docetaxel—head and neck cancer	0.00267	0.00298	CcSEcCtD
Cilazapril—Chills—Docetaxel—head and neck cancer	0.00265	0.00296	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00265	0.00296	CcSEcCtD
Cilazapril—Arrhythmia—Docetaxel—head and neck cancer	0.00264	0.00295	CcSEcCtD
Cilazapril—Nausea—Vinblastine—head and neck cancer	0.00263	0.00294	CcSEcCtD
Cilazapril—Insomnia—Fluorouracil—head and neck cancer	0.00263	0.00294	CcSEcCtD
Cilazapril—Paraesthesia—Fluorouracil—head and neck cancer	0.00261	0.00292	CcSEcCtD
Cilazapril—Alopecia—Docetaxel—head and neck cancer	0.00261	0.00292	CcSEcCtD
Cilazapril—Dyspnoea—Fluorouracil—head and neck cancer	0.00259	0.0029	CcSEcCtD
Cilazapril—Somnolence—Fluorouracil—head and neck cancer	0.00258	0.00289	CcSEcCtD
Cilazapril—Vomiting—Hydroxyurea—head and neck cancer	0.00257	0.00287	CcSEcCtD
Cilazapril—Dyspepsia—Fluorouracil—head and neck cancer	0.00256	0.00286	CcSEcCtD
Cilazapril—Rash—Hydroxyurea—head and neck cancer	0.00254	0.00285	CcSEcCtD
Cilazapril—Dermatitis—Hydroxyurea—head and neck cancer	0.00254	0.00284	CcSEcCtD
Cilazapril—ACE—head—head and neck cancer	0.00253	0.0238	CbGeAlD
Cilazapril—Headache—Hydroxyurea—head and neck cancer	0.00253	0.00283	CcSEcCtD
Cilazapril—Decreased appetite—Fluorouracil—head and neck cancer	0.00252	0.00282	CcSEcCtD
Cilazapril—Dysgeusia—Docetaxel—head and neck cancer	0.00252	0.00281	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00251	0.00281	CcSEcCtD
Cilazapril—SLC15A2—thyroid gland—head and neck cancer	0.00249	0.0234	CbGeAlD
Cilazapril—Pain—Fluorouracil—head and neck cancer	0.00248	0.00278	CcSEcCtD
Cilazapril—Muscle spasms—Docetaxel—head and neck cancer	0.00247	0.00276	CcSEcCtD
Cilazapril—Nausea—Hydroxyurea—head and neck cancer	0.0024	0.00268	CcSEcCtD
Cilazapril—Feeling abnormal—Fluorouracil—head and neck cancer	0.00239	0.00268	CcSEcCtD
Cilazapril—Anaemia—Docetaxel—head and neck cancer	0.00237	0.00266	CcSEcCtD
Cilazapril—Urticaria—Fluorouracil—head and neck cancer	0.00231	0.00258	CcSEcCtD
Cilazapril—Syncope—Docetaxel—head and neck cancer	0.0023	0.00258	CcSEcCtD
Cilazapril—Leukopenia—Docetaxel—head and neck cancer	0.0023	0.00257	CcSEcCtD
Cilazapril—Palpitations—Docetaxel—head and neck cancer	0.00227	0.00254	CcSEcCtD
Cilazapril—Loss of consciousness—Docetaxel—head and neck cancer	0.00226	0.00253	CcSEcCtD
Cilazapril—Cough—Docetaxel—head and neck cancer	0.00224	0.00251	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—head and neck cancer	0.00222	0.00248	CcSEcCtD
Cilazapril—SLC15A2—head—head and neck cancer	0.00221	0.0208	CbGeAlD
Cilazapril—Chest pain—Docetaxel—head and neck cancer	0.00219	0.00245	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—head and neck cancer	0.00219	0.00245	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—head and neck cancer	0.00219	0.00245	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00217	0.00243	CcSEcCtD
Cilazapril—Hypersensitivity—Fluorouracil—head and neck cancer	0.00214	0.00239	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—head and neck cancer	0.00214	0.00239	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—head and neck cancer	0.00211	0.00236	CcSEcCtD
Cilazapril—Oedema—Docetaxel—head and neck cancer	0.0021	0.00235	CcSEcCtD
Cilazapril—Shock—Docetaxel—head and neck cancer	0.00206	0.00231	CcSEcCtD
Cilazapril—Pruritus—Fluorouracil—head and neck cancer	0.00205	0.0023	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—head and neck cancer	0.00205	0.0023	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—head and neck cancer	0.00205	0.00229	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—head and neck cancer	0.00204	0.00228	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—head and neck cancer	0.002	0.00224	CcSEcCtD
Cilazapril—Diarrhoea—Fluorouracil—head and neck cancer	0.00199	0.00222	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—head and neck cancer	0.00196	0.00219	CcSEcCtD
Cilazapril—Dizziness—Fluorouracil—head and neck cancer	0.00192	0.00215	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00191	0.00214	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—head and neck cancer	0.0019	0.00212	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—head and neck cancer	0.00188	0.00211	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—head and neck cancer	0.00187	0.00209	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—head and neck cancer	0.00186	0.00209	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—head and neck cancer	0.00185	0.00207	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—head and neck cancer	0.00185	0.00206	CcSEcCtD
Cilazapril—Rash—Fluorouracil—head and neck cancer	0.00183	0.00205	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—head and neck cancer	0.00183	0.00205	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—head and neck cancer	0.00182	0.00204	CcSEcCtD
Cilazapril—Headache—Fluorouracil—head and neck cancer	0.00182	0.00204	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00181	0.00202	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—head and neck cancer	0.00181	0.00202	CcSEcCtD
Cilazapril—Constipation—Docetaxel—head and neck cancer	0.00179	0.00201	CcSEcCtD
Cilazapril—Pain—Docetaxel—head and neck cancer	0.00179	0.00201	CcSEcCtD
Cilazapril—ACE—lymph node—head and neck cancer	0.00177	0.0167	CbGeAlD
Cilazapril—Feeling abnormal—Docetaxel—head and neck cancer	0.00173	0.00193	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—head and neck cancer	0.00173	0.00193	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00171	0.00192	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—head and neck cancer	0.00166	0.00185	CcSEcCtD
Cilazapril—SLC15A2—lymph node—head and neck cancer	0.00154	0.0145	CbGeAlD
Cilazapril—Hypersensitivity—Docetaxel—head and neck cancer	0.00154	0.00173	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—head and neck cancer	0.0015	0.00168	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—head and neck cancer	0.00148	0.00166	CcSEcCtD
Cilazapril—ABCB1—epithelium—head and neck cancer	0.00143	0.0135	CbGeAlD
Cilazapril—Diarrhoea—Docetaxel—head and neck cancer	0.00143	0.0016	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—head and neck cancer	0.00139	0.00155	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—head and neck cancer	0.00133	0.00149	CcSEcCtD
Cilazapril—Rash—Docetaxel—head and neck cancer	0.00132	0.00148	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—head and neck cancer	0.00132	0.00148	CcSEcCtD
Cilazapril—Headache—Docetaxel—head and neck cancer	0.00131	0.00147	CcSEcCtD
Cilazapril—ABCB1—trachea—head and neck cancer	0.00127	0.0119	CbGeAlD
Cilazapril—Nausea—Docetaxel—head and neck cancer	0.00125	0.00139	CcSEcCtD
Cilazapril—ABCB1—lymphoid tissue—head and neck cancer	0.00111	0.0104	CbGeAlD
Cilazapril—ABCB1—thyroid gland—head and neck cancer	0.001	0.00945	CbGeAlD
Cilazapril—ABCB1—head—head and neck cancer	0.000891	0.00838	CbGeAlD
Cilazapril—ABCB1—lymph node—head and neck cancer	0.000624	0.00587	CbGeAlD
